Status:

COMPLETED

Analysis of in Vitro Biological Reaction of Diaphragmatic Prothesis When Congenital Diaphragmatic Hernia (CDH) Repair

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Congenital Diaphragmatic Repair

Eligibility:

All Genders

Up to 14 years

Brief Summary

In case of CDH, the incomplete development of a part of the diaphragm allows abdominal viscera to herniate into thorax cavity during fetal development and impaired lung and heart development. After b...

Eligibility Criteria

Inclusion

  • Minor aged 0 (day of birth) to 14 years
  • Patient for whom an indication of posthectomy and / or cure of inguinal hernia and / or testicular ectopy is retained
  • Patient whose legal representatives have agreed to the use of operational waste from mesenchymal tissues (foreskin, cremaster and peritoneum) destined for incineration.
  • Patient affiliated to a social security scheme

Exclusion

  • \- parents don't agree to the use of its operating waste for research purposes

Key Trial Info

Start Date :

May 29 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 31 2023

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT03316924

Start Date

May 29 2018

End Date

May 31 2023

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Les Hôpitaux Universitaires de Strasbourg

Strasbourg, France, 67098

Analysis of in Vitro Biological Reaction of Diaphragmatic Prothesis When Congenital Diaphragmatic Hernia (CDH) Repair | DecenTrialz